NDATOPICALOINTMENT
Approved
Oct 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TOPICORT (desoximetasone) by PharmaIN is corticosteroid hormone receptor agonists [moa]. Approved for plaque psoriasis in patients 18 years of age, older (), older and 1 more indications. First approved in 1983.
Drug data last refreshed 11h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TOPICORT (desoximetasone) is a potent topical corticosteroid that works by agonizing corticosteroid hormone receptors to suppress inflammation and immune function. It is indicated for plaque psoriasis in adult patients (18 years and older). The drug is formulated as an ointment for direct topical application to affected skin areas.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100); team size and resources likely constrained or reallocating to pipeline assets.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Indications (4)
Worked on TOPICORT at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.